PBYI
NASDAQ
$8.58
Puma Biotechnology Inc (PBYI)
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care in the United States and internationally. The company is headquartered in Los Angeles, California.
Sector:
Healthcare
Industry:
Biotechnology
Hold
Target: $5 (-41.72%)
Market Cap
$428M
PEG Ratio
0.03
Forward P/E
3.46
P/E Ratio
17.32
Price Chart
Valuation
Market Cap$428M
P/E17.32
Forward P/E3.46
PEG0.03
P/S1.85
P/B3.21
Profitability
Total Revenue (TTM)$227M
Gross Profit (TTM)$169M
EBITDA$40M
Profit Margin-8.4%
Operating Margin-8.5%
EPS$0.49
Financial Health
Debt-to-Equity8.8%
Free Cash Flow Yield12.51%
Growth & Risk
Revenue 5Y CAGR-3.54%
FCF 5Y CAGR+13.89%
Beta (5Y)0.78
Sharpe Ratio1.60